Skip to content
Homepage
Author:
Elutia Inc.
Posted Date:
August 18, 2026
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
Elutia Inc.
August 18, 2026
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market
Elutia Inc.
August 17, 2026
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
Elutia Inc.
August 13, 2026
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
Elutia Inc.
July 31, 2026
Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch
Elutia Inc.
July 16, 2026
